Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations - Top-Institutions - MDSpire

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

  • By

  • Raffaella Greco

  • Tobias Alexander

  • Joachim Burman

  • Nicoletta Del Papa

  • Jeska de Vries-Bouwstra

  • Dominique Farge

  • Jörg Henes

  • Majid Kazmi

  • Kirill Kirgizov

  • Paolo A. Muraro

  • Elena Ricart

  • Montserrat Rovira

  • Riccardo Saccardi

  • Basil Sharrack

  • Emilian Snarski

  • Barbara Withers

  • Helen Jessop

  • Claudia Boglione

  • Ellen Kramer

  • Manuela Badoglio

  • Myriam Labopin

  • Kim Orchard

  • Selim Corbacioglu

  • Per Ljungman

  • Malgorzata Mikulska

  • Rafael De la Camara

  • John A. Snowden

  • May 24, 2021

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Barcelona, Catalonia

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Autoimmune Disorders
    • Transplant Infectious Disease Management

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Autoimmune Disease Research
    • Immunology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Autoimmune Disorders

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, Washington

    Key Differentiators

    • Stem Cell Transplantation
    • Immunotherapy
    • Autoimmune Disease

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Autoimmune Disorders

Original Source(s)

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

  • by Raffaella Greco, Tobias Alexander, Joachim Burman, Nicoletta Del Papa, Jeska de Vries-Bouwstra, Dominique Farge, Jörg Henes, Majid Kazmi, Kirill Kirgizov, Paolo A. Muraro, Elena Ricart, Montserrat Rovira, Riccardo Saccardi, Basil Sharrack, Emilian Snarski, Barbara Withers, Helen Jessop, Claudia Boglione, Ellen Kramer, Manuela Badoglio, Myriam Labopin, Kim Orchard, Selim Corbacioglu, Per Ljungman, Malgorzata Mikulska, Rafael De la Camara, John A. Snowden

  • May 24, 2021

Related Content

ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP)

SARS-CoV-2 infection complicated by acute longitudinally extensive transverse myelitis and pulmonary embolism: a case report

Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation